BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35409142)

  • 1. A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells.
    Garofano F; Sharma A; Abken H; Gonzalez-Carmona MA; Schmidt-Wolf IGH
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells.
    Garofano F; Schmidt-Wolf IGH
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
    Li Y; Sharma A; Hoffmann MJ; Skowasch D; Essler M; Weiher H; Schmidt-Wolf IGH
    Front Immunol; 2024; 15():1268652. PubMed ID: 38558822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
    Qiao Z; Kumar A; Kumar P; Song ZH
    Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
    Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).
    Kaplan BL; Springs AE; Kaminski NE
    Biochem Pharmacol; 2008 Sep; 76(6):726-37. PubMed ID: 18656454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cannabinoids Effect on Bone Formation and Bone Healing.
    Raphael-Mizrahi B; Gabet Y
    Curr Osteoporos Rep; 2020 Oct; 18(5):433-438. PubMed ID: 32705630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Expression of Cannabinoid CB
    Lillo J; Raïch I; Silva L; Zafra DA; Lillo A; Ferreiro-Vera C; Sánchez de Medina V; Martínez-Orgado J; Franco R; Navarro G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077095
    [No Abstract]   [Full Text] [Related]  

  • 15. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
    Galaj E; Xi ZX
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Effects of PKCι on Anti-tumor Activity of Cytokine-induced Killer Cells Against Pancreatic Cancer Cells and the Possible Underlying Mechanisms].
    Zhang HM; Wang YR; Yang JH; Leng XH; Wang PP; Li ZX; Zhu TB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):821-826. PubMed ID: 31880112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine immune cells express high levels of CB
    Brown C; Mitsch M; Blankenship K; Campbell C; Pelanne M; Sears J; Bell A; Olivier AK; Ross MK; Archer T; Kaplan BLF
    Vet Immunol Immunopathol; 2023 Nov; 265():110667. PubMed ID: 37931433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
    Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.